Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

BIONPHARMA INC

  • FDA Approval
  • Oct. 12, 2022, 01:36 UTC
  • 30
  • 0 comments

FDA approve FINGOLIMOD

Comment Full text

APOTEX INC

  • FDA Approval
  • Oct. 12, 2022, 01:36 UTC
  • 27
  • 0 comments

FDA approve CITALOPRAM HYDROBROMIDE

Comment Full text

SCPHARMACEUTICALS INC

  • FDA Approval
  • Oct. 11, 2022, 10:57 UTC
  • 27
  • 0 comments

FDA approve FUROSEMIDE

Comment Full text

HIKMA PHARMACEUTICALS USA, INC

  • FDA Approval
  • Oct. 11, 2022, 10:47 UTC
  • 28
  • 0 comments

FDA approve CEFAZOLIN

Comment Full text

ABBVIE

  • FDA Approval
  • Oct. 11, 2022, 10:26 UTC
  • 27
  • 0 comments

FDA approve CISATRACURIUM BESYLATE

Comment Full text

SUPERNUS PHARMS

  • FDA Approval
  • Oct. 11, 2022, 10:22 UTC
  • 28
  • 0 comments

FDA approve TOPIRAMATE

Comment Full text

MYLAN

  • FDA Approval
  • Oct. 10, 2022, 01:37 UTC
  • 28
  • 0 comments

FDA approve AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM

Comment Full text

VIIV HLTHCARE

  • FDA Approval
  • Oct. 10, 2022, 01:37 UTC
  • 28
  • 0 comments

FDA approve ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE

Comment Full text

VIIV HLTHCARE

  • FDA Approval
  • Oct. 10, 2022, 01:37 UTC
  • 25
  • 0 comments

FDA approve DOLUTEGRAVIR SODIUM

Comment Full text

VIIV HLTHCARE

  • FDA Approval
  • Oct. 10, 2022, 01:37 UTC
  • 27
  • 0 comments

FDA approve DOLUTEGRAVIR SODIUM; LAMIVUDINE

Comment Full text
  • Previous
  • 969
  • 970
  • 971
  • 972
  • 973
  • Next

Search

News categories

  • Technical Exchange News(12342)
  • Event(6229)
  • SEC News(270090)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(157424)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin